Semaglutide (Ozempic, Wegovy) is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist
Adding Ozempic to endoscopic sleeve gastrectomy produces greater weight loss Using Ozempic in combination with endoscopic sleeve gastrectomy resulted in greater weight loss than the procedure alone, according to a presentation at Digestive Diseases Week
Life-Changing Events & Perspective 02:25:45 Death, Spontaneous Cancer Remission
Medical Weight Loss What is Medical Weight Loss
Eli Lilly's pill is a different drug from its shots, and it appears to be less effective than its shots
The medication works by mimicking GLP-1's actions on multiple body systems to promote weight loss through several complementary mechanisms